Ligand Binding by Antibody IgE Lb4: Assessment of Binding Site Preferences Using Microcalorimetry, Docking, and Free Energy Simulations  by Sotriffer, Christoph A. et al.
Ligand Binding by Antibody IgE Lb4: Assessment of Binding Site
Preferences Using Microcalorimetry, Docking, and Free
Energy Simulations
Christoph A. Sotriffer,* Wolfgang Flader,* Alan Cooper,# Bernd M. Rode,* D. Scott Linthicum,§ Klaus R. Liedl,*
and Janos M. Varga*
*Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, A-6020 Innsbruck, Austria; #Department of Chemistry,
Glasgow University, Glasgow G12 8QQ, Scotland; and §Department of Pathobiology, Texas A & M University,
College Station, Texas 77843-4467 USA
ABSTRACT Antibody IgE Lb4 interacts favorably with a large number of different compounds. To improve the current
understanding of the structural basis of this vast cross-reactivity, the binding of three dinitrophenyl (DNP) amino acids
(DNP-alanine, DNP-glycine, and DNP-serine) is investigated in detail by means of docking and molecular dynamics free
energy simulations. Experimental binding energies obtained by isothermal titration microcalorimetry are used to judge the
results of the computational studies. For all three ligands, the docking procedure proposes two plausible subsites within the
binding region formed by the antibody CDR loops. By subsequent molecular dynamics simulations and calculations of relative
free energies of binding, one of these subsites, a tyrosine-surrounded pocket, is revealed as the preferred point of
complexation. For this subsite, results consistent with experimental observations are obtained; DNP-glycine is found to bind
better than DNP-serine, and this, in turn, is found to bind better than DNP-alanine. The suggested binding mode makes it
possible to explain both the moderate binding affinity and the differences in binding energy among the three ligands.
INTRODUCTION
Antibodies are generally considered to be highly specific
defense agents of the immune system against invading
antigens. In contrast to this general notion of specificity,
over the last several years a growing number of cross-
reactive antibodies has become known, which bind not only
the immunizing antigen, but also other ligands with similar
affinity (e.g., Richards et al., 1975; Czaja et al., 1976; Varga
et al., 1991a,b; Arevalo et al., 1993; Chitarra et al., 1993;
Carlin et al., 1994; Roggenbuck et al., 1994; Shreder et al.,
1996; Lamminma¨ki et al., 1997). Structurally, however,
only a small subset of these antibodies and their complexes
has been characterized so far, and consequently it was stated
that the structural basis for antibody polyreactivity is not yet
clear (Padlan, 1994).
Antibody IgE-Lb4 is an example of a highly cross-reac-
tive antibody. It belongs to a class of anti-trinitrophenyl
antibodies and was recognized to be heteroclitic, i.e., li-
gands different from the immunizing hapten are bound with
higher affinity (Furusawa and Ovary, 1988). Subsequently,
Lb4 was studied to characterize its binding properties in
more detail. Screening assays (Varga et al., 1991a) with
over 2000 different compounds revealed several classes of
molecules bound by Lb4, although in many cases no obvi-
ous structural similarities could be observed (Winger et al.,
1996). The variable region genes for IgE Lb4 were cloned
and sequenced (Kofler et al., 1992). The resulting informa-
tion was used to obtain the structure of the variable region
fragment (Fv) by homology modeling (Droupadi et al.,
1994). Comparative docking studies were then performed to
obtain first indications of how the binding of different
ligands could be understood in structural terms (Sotriffer et
al., 1996; Winger et al., 1996).
To further elucidate the structural and energetic basis of
the cross-reactive binding properties of antibody Lb4, this
work is focused on the investigation of the complexes
formed with three dinitrophenyl (DNP) amino acids (DNP-
alanine, DNP-glycine, and DNP-serine, as shown in Fig. 1).
To derive structural insights, a combination of computa-
tional approaches is used, including new docking searches
with refined procedures and free energy calculations using
molecular dynamics simulations. An experimental thermo-
dynamic analysis of the complexes is carried out by means
of isothermal titration microcalorimetry. The accurate ex-
perimental binding data obtained by this method allow us to
validate the results of the calculations.
The compounds investigated here were selected from the
pool of known Lb4-ligands based on requirements of the
free energy simulation method. Therefore three DNP-amino
acids were chosen that show only slight structural differ-
ences among themselves. This makes the simulations more
feasible and helps to avoid more severe sampling and con-
vergence problems. Furthermore, the nature of the chosen
ligands allows us to calculate the relative free energy dif-
ference for all three ligand pairs in turn and thus to carry out
an internal consistency check of the results. The disadvan-
tage of the structural similarity of the ligands is that differ-
ences in binding free energy could turn out to be relatively
small. However, as shown in an excellent study by Pearl-
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man and Connelly (1995), who analyzed the effect of a
tyrosine-to-phenylalanine mutation associated with a 0.60
kcal/mol change in ligand affinity, minor free energy dif-
ferences can also be successfully analyzed if the structural
prerequisites are met and sensible simulation protocols are
applied.
MATERIALS AND METHODS
Microcalorimetry
Isothermal titration calorimetry (ITC) experiments to measure the binding
of DNP-amino acids (DNP-Ala, DNP-Gly, DNP-Ser) to Lb4 were con-
ducted at 25°C, using a Microcal OMEGA titration microcalorimeter and
following standard instrumental procedures (Wiseman et al., 1989; Cooper
and Johnson, 1994; Fisher and Singh, 1995), with a 250-l injection
syringe and 400 rpm stirring. The monoclonal antibody Lb4 was purified
to homogeneity by affinity chromatography as described (Droupadi et al.,
1994), subsequently dialyzed overnight at 4°C in buffer (50 mM sodium
phosphate, 0.1 M NaCl, 0.01% sodium azide, pH 7.2), and gently degassed
immediately before use. DNP-ligands were dissolved in the same dialysis
buffer. Protein concentrations in the ITC cell were determined from UV
absorbance measurements at 280 nm, using 280  239,000 as the molar
extinction coefficient. A typical binding experiment involved 25  10-l
injections of ligand solution (typically around 0.4 mM concentration) into
the ITC cell (1.3 ml active volume) containing protein (10 M).
Control experiments were performed under identical conditions by injec-
tion of the ligand into buffer alone (to correct for heats of ligand dilution)
and injection of buffer into the protein mix (to correct for heats of dilution
of the protein). Integrated heat effects, after correction for heats of dilution,
were analyzed by nonlinear regression in terms of a simple single-site
binding model, using the standard Microcal ORIGIN software package.
For each thermal titration curve, this yields estimates of the apparent
number of binding sites (N) on the protein, the binding constant (K [M1];
also expressed as the reciprocal dissociation constant, Kdiss [M]), and the
enthalpy of binding (H [kcal/mol]). Other thermodynamic quantities were
calculated using standard expressions: G°  RT ln K  H°  TS°.
Docking
The Fv structure of Lb4 obtained by means of homology modeling by
Droupadi et al. (1994) was used for all computational studies. For anti-
bodies, this method of structure prediction is sufficiently reliable, given the
special characteristics of this class of proteins (stability of the immuno-
globulin-fold; limited number of canonical structures for the hypervariable
loops; Chothia and Lesk, 1987) and the availability of a large number of
experimental structures (Padlan, 1996). Examination of the Lb4 sequence
revealed that key residues known to create specific canonical conforma-
tions of the complementarity determining region (CDR) loops are present
in the required positions. Furthermore, no insertions or deletions were
needed in the “parent” loop structures selected as templates for the CDR
loops of Lb4. These two facts not only facilitated the modeling process, but
also increased the reliability of the Lb4 structure obtained.
Docking was performed with version 2.4 of the program AutoDock
(Morris et al., 1996; Goodsell and Olson, 1990). For consistency with
subsequent molecular dynamics (MD) simulations, the force-field param-
eters were taken from the new AMBER force field (Cornell et al., 1995).
This required the assignment of the corresponding charges to Lb4 as well
as charge calculations for the ligands by fitting to the HF/6–31G* elec-
trostatic potential. The necessary ab initio calculations were performed
with GAUSSIAN94 (Frisch et al., 1995), the restrained electrostatic po-
tential fit with the RESP program (Bayly et al., 1993; Cornell et al., 1993).
Following the philosophy of the new AMBER force field, no special
hydrogen bonding term was applied. For evaluation of the Coulomb
interactions, a sigmoidal distance-dependent dielectric function was used
(Mehler and Solmajer, 1991). The affinity grids were centered on the
CDRs, with dimensions of 45 Å  36 Å  43 Å and a grid spacing of 0.5
Å. The simulated annealing search process was started at a temperature
corresponding to RT  1200 cal/mol, which was reduced by a factor of
0.90 after each cycle. A cycle consisted of a maximum of 30,000 accepted
or rejected steps, where a step corresponds to a random change in trans-
lational, rotational, and torsional degrees of freedom of the ligand. One
hundred such cycles were performed per docking run, and for each ligand
100 independent docking runs were carried out.
In numerous studies AutoDock has been shown to successfully repro-
duce experimental protein-ligand interaction geometries (Goodsell and
Olson, 1990; Goodsell et al., 1993; Friedman et al., 1994; Morris et al.,
1996; Coutinho et al., 1997). The parameters used here were tested on an
antibody-hapten complex (AN02; Bru¨nger et al., 1991) used in a previous
study (Sotriffer et al., 1996). The success rate obtained with the new
protocol was higher, with 54 of 100 runs reproducing the x-ray structure
and being correctly ranked with top docking energies. Again, only one
alternative result orientation was found in the rest of the runs and ranked
with considerably worse energy. Further studies on experimental antibody-
hapten complexes using this docking method are presented elsewhere
(Sotriffer et al., 1999).
Free energy simulations
Differences in free energy of binding to Lb4 were calculated for DNP-Ala
relative to DNP-Gly, DNP-Ser relative to DNP-Ala, and DNP-Ser relative
to DNP-Gly. This allowed us to establish a closed thermodynamic cycle
(DNP-Ser 3 DNP-Ala 3 DNP-Gly 3 DNP-Ser) as an internal consis-
tency check (Mark et al., 1994; Essex et al., 1997), as the free energy
change in a closed cycle should obviously be 0, irrespective of the meth-
odology used for its evaluation. Calculations were performed for two
different binding orientations suggested by the docking procedure.
Relative free energies of binding were obtained by the technique of
thermodynamic integration (TI) along nonphysical pathways, where ligand
1 is mutated into ligand 2, both in aqueous solution and complexed to the
antibody in solution. The method is described and reviewed in several
articles (Beveridge and DiCapua, 1989; Reynolds et al., 1992; Straatsma
and McCammon, 1992; Kollman, 1993; Pearlman, 1994; Pearlman and
Connelly, 1995; Straatsma, 1996; Helms and Wade, 1997). A thermody-
FIGURE 1 Structures of the investigated ligands.
FIGURE 2 Thermodynamic cycle for the evaluation of relative free
energies of binding.
Sotriffer et al. Ligand Binding by Antibody IgE Lb4 2967
namic cycle as shown in Fig. 2 was used to establish the relationships
between the molecular states under consideration.
The horizontal arrows in Fig. 2 indicate the process of binding between
the antibody and the ligand, with the experimentally accessible binding free
energies G3 and G4. The vertical directions represent the “alchemical
process” (Straatsma and McCammon, 1992) corresponding to the “muta-
tion” of the ligand, both in solution (G1) and complexed by the antibody
(G2). These “mutational pathways” are computationally more easily
accessible than the real binding processes given by the horizontal arrows.
Through the thermodynamic cycle, however, experimental and theoretical
binding energies are directly comparable: because free energy is a state
function, G2  G1 is equal to G4  G3, and thus the relative free
energy of binding G can be obtained by experiment as well as by
simulation.
To calculate the free energy difference G between two states A and B
by thermodynamic integration, the potential functions VA(r
N) and VB(r
N)
corresponding to states A and B and depending on the coordinates rN of all
atoms in the system, are connected by a so-called coupling parameter .
The potential function changes from VA to VB as  is varied from 0 to 1:
V, rN 1 VArN VBrN.
G is then obtained as
G 
0
1V, rN



d
where the angle brackets 	 
 represent an ensemble average at a given .
The integral is calculated by evaluating the integrand at a series of discrete
 values (“windows”) and applying the trapezoidal method as a numerical
integration algorithm.
All simulations and free energy calculations were carried out with the
AMBER4.1 series of programs (Pearlman et al., 1995a,b), using the new
AMBER force field (Cornell et al., 1995). Six starting configurations had
to be prepared: DNP-Ala and DNP-Ser uncomplexed in solution, and
DNP-Ala and DNP-Ser complexed to Lb4, each in two different positions.
DNP-Ser was used as starting point for the mutations to both DNP-Ala and
DNP-Gly, whereas DNP-Ala served only as the starting point for mutations
to DNP-Gly. By this setup no definition of dummy atoms in the starting
systems was required. The atom types assigned to the ligand atoms are
shown in Fig. 3. Additional force-field parameters required for structural
units that are not covered by the standard AMBER force field are listed in
Table 1. They were derived in comparison with existing parameters,
experimental data, and results from ab initio calculations.
The free (unbound) ligands were solvated in a rectangular box of TIP3P
water molecules (Jorgensen et al., 1983) with a minimum solute-wall
distance of 10 Å. This resulted in a box size of 30 Å  26 Å  24 Å and
510 water molecules within the box. In a first step the systems were
energy minimized, to optimize the distribution of the water molecules
around the solute. Subsequently, MD simulations were started to equili-
brate the systems for the following free energy calculations. After 10 ps of
initial gradual heatup to a temperature of 300 K, a further 40 ps was
simulated under NPT conditions (300 K and 1 atm) with full periodic
boundary conditions. The temperature was kept constant by coupling to a
heat bath through the Berendsen algorithm (Berendsen et al., 1984). Pres-
sure was adjusted by isotropic position scaling. All covalent bonds were
constrained by the SHAKE algorithm (Ryckaert et al., 1977), and a time
step of 2 fs was used. A residue-based cutoff of 8 Å was applied to the
noncovalent interactions; the pair list was updated every 10 time steps
(0.02 ps).
The complexes were set up for simulation in a similar way. The
antibodies with bound ligand where placed in TIP3P water boxes, while
maintaining a minimum solute-wall distance of 8 Å. This led to a box size
of 68 Å 65 Å 56 Å, with6100 water molecules and a total of 22,000
atoms. After initial energy minimization and subsequent start of MD
simulations with heatup to 300 K in 10 ps, the systems were equilibrated
for 90 ps, using the same simulation parameters as given above (for the
simulation of the ligands in solution).
The free energy calculations were started with the systems resulting
from the equilibration, using the same simulation parameters. The muta-
tions were carried out by the single topology technique, which requires the
definition of dummy atoms when the initial and final molecules have
different numbers of atoms. The dummy atoms have van der Waals
parameters equal to zero and carry no charge (i.e., no interaction with the
environment), and bond, angle, and torsional parameters are kept as in the
TABLE 1 Additional force-field parameters for the
DNP-ligands
Bonds Kb (kcal mol
1 Å2) r0 (Å)
CAONO 337.0 1.468
NOOON 656.0 1.217
Angles K (kcal mol
1 rad2) 0 (deg)
COCTON2 63.0 110.1
CAOCAONO 70.0 120.0
CAOCAON2 70.0 120.0
CAONOOON 70.0 117.0
ONONOOON 80.0 126.0
Dihedrals K (kcal mol
1) Phase (deg) Periodicity
CAOCAONOOON 9.6 180.0 2
Improper Dihedrals K (kcal mol
1) Phase (deg) Periodicity
CAOCAOCAONO 1.1 180.0 2
CAOCAOCAON2 1.1 180.0 2
CAOONONOOON 10.5 180.0 2
van der Waals
Parameters
 (kcal mol1) R* (Å)
ON 0.2100 1.6612
NO 0.1700 1.8240
FIGURE 3 Atom types assigned to the ligand atoms.
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nondummy state. The free energies were calculated, including all intra-
perturbed group contributions and applying the PMF corrections for con-
tributions arising from bond length changes (Pearlman and Kollman, 1991;
van Gunsteren and Mark, 1992; Pearlman and Connelly, 1995). Thermo-
dynamic integration was performed over 21 windows ( spacing 0.05) with
varying times of equilibration and data collection. For the free ligands in
solution, simulations were carried out with 2, 4, 6, and 10 ps for each
equilibration (eq) and data collection (dc) per window, resulting in total
simulation times of 84, 168, 252, and 420 ps, respectively. The complexes
were all simulated with 4 ps of equilibration and data collection, respec-
tively, for each window (168 ps total simulation time). For one complex
example (the mutation of DNP-Ala to DNP-Gly), a shorter and a longer
simulation were run as well (eq/dc/total of 2/2/84 and 10/10/420 ps) to
check the convergence behavior.
To avoid numerical instabilities, the mutations from DNP-Ser to DNP-
Gly were done with electrostatic decoupling, which implies that two
separate simulations have to be carried out. In the case of disappearing
atoms, the first simulation is used for the electrostatic perturbation, and the
second serves to change the van der Waals parameters. This order is
reversed when the mutation is performed in the opposite direction, i.e.,
when atoms are generated. To avoid problems during particle deletion,
there are other approaches, such as the use of a soft-core potential (Beutler
et al., 1994) or separation-shifted potential scaling (Zacharias et al., 1994).
However, the two methods are not yet implemented in the standard
AMBER program, although the former variant has already been used
successfully in combination with AMBER in a recent study by Simmerling
et al. (1998).
All simulations were done in the forward as well as the backward
direction. After each forward simulation, 20 ps of intrarun equilibration
was done on the   0 state before the mutation was started back toward
the   1 state.
RESULTS AND DISCUSSION
Experimental binding energies
Microcalorimetric titration experiments involving the addi-
tion of DNP-ligands to Lb4 in solution gave exothermic
heat pulses consistent with simple noncovalent binding of
ligand to identical antibody sites. Typical data are shown in
Fig. 4, and the thermodynamic data derived from these
experiments are summarized in Table 2.
Dissociation constants (Kdiss) are in the 5–15 M range,
corresponding to standard free energies of binding (G°)
between 7.3 and 6.6 kcal/mol. Variations in binding
enthalpies (H°) are somewhat larger between different
ligands, but are mainly offset by compensating changes in
entropy of binding (S°). Comparison with an extensive list
of association constants of monoclonal antibodies for hap-
tens (Chappey et al., 1994) shows that the binding data
obtained here are within the range of what is generally
observed but also suggests that the analyzed ligands are
bound with comparatively moderate affinity.
As far as the relative free energies of binding are con-
cerned, the binding strength increases in going from DNP-
Ala over DNP-Ser to DNP-Gly: DNP-Gly binds 0.5 kcal/
mol better than DNP-Ser and 0.7 kcal/mol better than DNP-
Ala. Regarding the enthalpic and entropic contributions, the
same range of magnitude is observed for DNP-Gly and
DNP-Ser, whereas the binding of DNP-Ala is characterized
by a somewhat larger enthalpic term and a greater loss in
entropy. This may reflect the fact that in contrast to the polar
Ser side chain, the methyl group of DNP-Ala is not inter-
acting with water through hydrogen bonds. Consequently,
the desolvation enthalpy is smaller and the resulting gain in
enthalpy upon binding is larger. Furthermore, the loss in
conformational flexibility is higher, leading to a more neg-
ative change in entropy.
Docking
The primary objective of docking DNP-Ala, DNP-Gly, and
DNP-Ser to Lb4 has been to obtain suggestions about prob-
able binding positions in the most suitable way for subse-
quent free energy calculations by MD simulations. To ac-
complish this task, it is preferable to use the same force-
field parameters for the docking procedure as for the
TABLE 2 Experimental thermodynamic data for DNP-ligand
binding to Lb4, determined by isothermal titration
microcalorimetry at 25°C, pH 7.2
DNP-Ala DNP-Gly DNP-Ser
Kdiss (M) 14.7 (2.4) 4.7 (0.5) 10.6 (1.0)
H° (kcal/mol) 24.4 (1.5) 19.3 (1.3) 19.4 (1.8)
S° (cal/mol K) 59.6 (5.4) 40.4 (4.5) 42.2 (6.4)
G° (kcal/mol) 6.6 (0.1) 7.3 (0.1) 6.8 (0.1)
FIGURE 4 Example of calorimetric data for binding of a DNP-ligand to
monoclonal antibody. (A) Raw ITC data for 25  10-l injections of
DNP-Ala (0.39 mM) into Lb4 solution (10 M) at 25°C, pH 7.2. (B)
Integrated heats from above, with the theoretical curve (solid line) corre-
sponding to 1:1 complexation with parameters given in Table 2, derived by
nonlinear regression as described in the text.
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simulations, to avoid discrepancies that could lead to arti-
facts and instabilities during optimization and equilibration.
In addition, the search of the configuration space should be
carried out as exhaustively as possible to localize all binding
alternatives and to analyze in detail whether all ligands can
bind in similar positions. The similarity is important for the
applicability of standard free energy perturbation tech-
niques, in which small perturbations and close resemblance
of the binding positions are advantageous. A former dock-
ing study on Lb4 (Sotriffer et al., 1996) had already re-
vealed binding possibilities for the three DNP-ligands.
However, these were obtained with different force-field
parameters and searches that were less extensive by an order
of magnitude, because a large number of compounds had to
be covered. Consequently, DNP-Ala, DNP-Gly, and DNP-
Ser have now been redocked to Lb4 as described in Mate-
rials and Methods, using considerably larger grids and in-
creasing the number of independent runs by a factor of 10.
The docking results obtained in this way are summarized
in Table 3. The 100 runs for each ligand gave 25 (DNP-
Ala), 33 (DNP-Gly), and 30 (DNP-Ser) different results
(i.e., positions differing by more than 1 Å root mean square
deviation (rmsd)). This is a less well-defined result than
observed for the AN02 test case mentioned above. It has to
be kept in mind, however, that the topology of the binding
site as well as the nature of the ligands are very different for
AN02 and Lb4: AN02 has a deep and narrow binding cleft
flanked by two tryptophans, and the AN02 DNP-ligand
carries two large, bulky substituents. In contrast, DNP-Ala,
DNP-Gly, and DNP-Ser are considerably smaller, and the
surface of Lb4 shows larger pockets that appear to be less
discriminating. As a consequence, obtaining sharply distrib-
uted docking results is more difficult for Lb4, and the
primary output needs some further analysis.
Upon visual inspection, the Lb4 results for the three
DNP-amino acids could be roughly classified into three
groups: a set of results located in a tyrosine-formed pocket
(which will be called subsite 1 (S1)), another set accommo-
dated in the cleft already known from the previous docking
study (which will be called subsite 2 (S2)), and finally, a
heterogeneous group of results found at various locations
outside the CDRs and in positions at the top of the surface,
where they do not enter any cleft and appear to be bound
rather loosely.
The two binding pockets are close neighbors within the
CDR region of Lb4, but they are separated by a short
segment of the CDR H3 loop, from Trp H95 to Ile H98 (H
and L denote heavy and light chain, respectively; residues
are numbered according to the system of Kabat et al.
(1991)). Subsite 1 is primarily formed by CDR H3. Three
tyrosine side chains (Tyr H32, Tyr H102, and Tyr L49)
mark the spatial limits of this subsite. Together with these
tyrosines, Arg H94, Trp H95, Gly H96, Ile H98, and Lys
L50 are among the most important contact residues. For
subsite 2, CDR H3 forms the border with Trp H95 and Leu
H97 as primary contact residues. Residues from CDR L1
(His L27D, Tyr L32) and CDR L3 (Gly L91, Ser L92, Val
L94), as well as Tyr H50 from CDR L2 are important
interaction partners as well. Figs. 5 and 6 give an impression
of the architecture of the subsites (both figures were pre-
pared using MOLSCRIPT; Kraulis, 1991).
TABLE 3 Overview of docking results
Ntot Ndiff
E
(kcal/mol)
dS1
(Å)
dS2
(Å)
DNP-Ala
Total 100 25 28.36 to 19.25 — —
Results in S1 20 3 25.58 5.1 13.0
Results in S2 7 4 23.83 11.3 3.7
Other results 73 18 25.97 16.4 18.6
DNP-Gly
Total 100 33 30.37 to 21.21 — —
Results in S1 7 3 27.61 3.8 12.0
Results in S2 13 5 23.13 11.1 3.2
Other results 80 25 24.98 16.4 18.2
DNP-Ser
Total 100 30 25.66 to 17.90 — —
Results in S1 15 3 23.54 5.1 12.9
Results in S2 20 5 20.41 11.7 4.2
Other results 65 22 22.49 17.3 20.1
Ntot is the total number of results; Ndiff is the number of results differing by
more than 1 Å rmsd; E is the docking energy. In the Total line the energy
range of all results is given, whereas the other lines contain the average
energy of the respective results. S1 and S2 are the two subsites, and dS1
and dS2 are the distances from the ligand center to the subsite center. The
subsite centers are defined as the geometrical centers of the contact
residues given in Table 4. All averages are weighted by the occurrence
frequency of each result.
FIGURE 5 Architecture of the Lb4 subsites S1 (top) and S2 (bottom)
with DNP-Ala as bound ligand, showing the DNP-Ala docking results and
contact residues listed in Table 4.
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Measuring the distances between geometric subsite cen-
ters and geometric centers of the ligands provides a useful
overview of the location of the results. The residues men-
tioned above (which are also listed in Table 4) were used to
define the subsite centers. With this definition, the S1 center
turns out to be 9.0 Å from the S2 center. Structures accom-
modated within one of the subsites show, in general, dis-
tances to the subsite centers of 2.9–5.9 Å. Average values
for all results are given in Table 3.
To summarize the data, the docking procedure has repro-
posed the binding site (S2) found in previous work
(Sotriffer et al., 1996; Winger et al., 1996). In addition, it
has revealed a new site within the CDRs (S1), where favor-
able interactions are possible. According to the docking
energies, binding to S1 should even be more favorable than
binding to S2. Docking positions outside these two sites are
not taken into further consideration. Although some mem-
bers of this set show good docking energies and occur with
high frequency (especially in the case of DNP-Ala), they are
classified as artifacts and false positives because of their
location outside the CDRs or because of their “superficial”
sticking to the surface.
Starting configurations for subsequent free energy simu-
lations were thus selected from S1 and S2 results. The
chosen results are presented in detail in Table 4. The selec-
tion was based primarily on the similarity with results of the
other ligands. As described in Materials and Methods sec-
tion, simulations were started from DNP-Ala and DNP-Ser;
therefore no DNP-Gly complex structure was required as
starting point. Nevertheless, it had to be ensured that DNP-
Gly shows the same binding mode as the other two ligands.
In both subsites highly overlapping results were found for
all three ligands. Consequently, simulations were started for
both types of complexes (S1 and S2) to strengthen support
for one or the other of the two subsites as the primary
binding site. To analyze the similarity of the binding posi-
tions, the atoms of the conserved DNP part were used to
measure the rmsd between the three molecules. Very low
values were obtained for DNP-Ala and DNP-Gly, which
bind almost identically in both subsites (rmsd of 0.98 Å in
S1 and 0.33 Å in S2). As expected from the more different
side chain of DNP-Ser, the fit is not as close for DNP-Ala
and DNP-Ser (1.94 Å in S1 and 3.94 Å in S2) or DNP-Gly
and DNP-Ser (2.52 Å in S1 and 3.95 Å in S2). In S1 the
difference in DNP-Ser arises from a somewhat larger dis-
tance to Tyr H102, which is probably due to a hydrogen
bond of the hydroxyl group with Lys L50. In S2 the aro-
matic part of DNP-Ser lies in the same plane as the aromatic
rings of DNP-Ala and DNP-Gly, but with different orien-
tations of the nitro groups and with closer contact to Gly
L91 instead of Val L94 and His L27D. Despite these vari-
ations, the positions obtained for DNP-Ser can serve as
starting point for free energy simulations and mutations
toward DNP-Ala and DNP-Gly, as all results have been
obtained by docking to a rigid antibody, and the inclusion of
full flexibility may level off these differences.
Free energy calculations
Energetics
The perturbation of one ligand into the other in solution is
the first step in calculations of relative free energies of
FIGURE 6 The complete Lb4 binding site with DNP-Ala as bound
ligand, displayed simultaneously in S1 (right) and S2 (left), showing the
DNP-Ala docking results and contact residues listed in Table 4.
TABLE 4 Docking results selected for investigation by free
energy simulations (energies in kcal/mol)
DNP-Ala DNP-Gly DNP-Ser
Subsite 1
Energy 25.68 24.48 21.10
Total occurrence frequency 17 1 1
No. of contacts with
Tyr H 32 20 21 19
Arg H 94 2 5 —
Trp H 95 7 8 5
Gly H 96 — 2 6
Ile H 98 15 18 19
Tyr H 102 14 19 3
Tyr L 49 7 8 8
Lys L 50 2 1 7
Subsite 2
Energy 24.45 24.22 19.94
Total occurrence frequency 4 4 3
No. of contacts with:
Tyr H 50 — — 9
Trp H 95 4 3 8
Leu H 97 23 9 8
His L 27D 14 14 7
Tyr L 32 5 11 10
Gly L 91 2 3 11
Ser L 92 5 6 —
Val L 94 14 14 1
Contact residues are shown only if at least one of the ligands has at least
five contacts with the residue. Atomic van der Waals contacts are defined
as described by Sheriff et al. (1987).
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binding. The results of these simulations for the uncom-
plexed ligands are shown in the upper half of Table 5. The
values given in the table are the averages of two runs in
opposite directions (i.e., from   1 to 0 and from 0 to 1).
The hysteresis is the difference in the results for the forward
and the backward run; half of its value is often taken as a
crude error estimate (e.g., Fox et al., 1997). The last line of
the first part shows the average over all eight simulation
results (four simulations of different length, each done in
both the forward and backward directions), with the stan-
dard deviation as an estimate of precision. In the last column
the free energies of the three independent mutations are
combined to a closed cycle, which serves as a measure of
accuracy. It should be noted that the values presented here
for the single transformations themselves have no straight-
forward physical meaning and cannot be compared to any
experimental data, which is also partly due to the fact that
all intra-perturbed group contributions were included in the
calculations. Experimental observables arise only when the
values are combined to yield relative free energy differ-
ences, as shown in Table 6.
The average free energy for the mutation of DNP-Ala to
DNP-Gly in water is 27.4 kcal/mol, whereas mutating
DNP-Ser into DNP-Ala is associated with a free energy
change of 4.4 kcal/mol, and the perturbation of DNP-Ser
into DNP-Gly gives a value of 23.0 kcal/mol. Taken
together, these values lead to a perfect cycle closure energy
of 0.0 kcal/mol, which is somewhat fortuitous and is prob-
ably associated with an uncertainty of 1 kcal/mol, as esti-
mated from the combined standard deviations. The values
of the single simulations improve in quality with longer
simulation times, as indicated by smaller hystereses and
cycle closure errors. The perturbations required for mutat-
ing DNP-Ala into DNP-Gly and DNP-Ser into DNP-Ala are
rather simple. Already with short simulation times, fairly
TABLE 5 Calculated free energies (in kcal/mol) A, G, S stand for DNP-Ala, DNP-Gly, DNP-Ser, respectively
Simulation Times eq/dc/total (ps) A 3 G S 3 A S 3 G
Cycle Closure:
A 3 G 3 S 3 A
Uncomplexed ligand in solution
2/2/84 27.37 (0.62) 3.97 (0.45) 22.79 (2.28) 0.61
20.45e, 2.35
4/4/168 27.20 (1.49) 4.94 (0.49) 23.15 (0.93) 0.89
20.57e, 2.59
6/6/252 27.49 (0.25) 4.26 (0.35) 22.72 (2.06) 0.51
20.38e, 2.34
10/10/420 27.48 (0.17) 4.61 (0.12) 23.14 (0.09) 0.27
20.25e, 2.89
Average
SD
27.39
0.43
4.44
0.41
22.95
0.83
0.00
(1.02)†
Complex: ligand in S1
2/2/84 28.22 (0.25)
4/4/168 28.89 (0.89) 4.72 (0.48) 24.30 (2.06) 0.13
21.06e, 3.23
10/10/420 28.98 (0.50)
Average
SD
28.70
0.46
Complex: ligand in S2
2/2/84 25.67 (0.61)
4/4/168 27.60 (3.51) 3.30 (0.41) 25.11 (1.82) 0.81
21.65e, 3.45
10/10/420 27.18 (0.83)
Average
SD
26.81
1.34
S1 and S2 refer to complexation at the two different subsites. Values in parentheses represent the hysteresis. For S3 G, electrostatic decoupling was used.
Therefore, in this column the lines following the composite result show the results of the decoupled runs, with e denoting the electrostatic part.
†Calculated as the root of the sum of the standard deviations squared.
TABLE 6 Relative free energies of binding calculated from
the averages of the uncomplexed ligand runs and the results
of the 4/4/168 complex runs, in comparison with
experimental values
A 3 G S 3 A S 3 G
Cycle Closure:
A 3 G 3 S 3 A
Exptl. G 0.7 0.2 0.5 0.0
S1 complexes
G complex 28.89 4.72 24.30 0.13
G uncomplexed 27.39 4.44 22.95 0.00
G 1.50 0.28 1.35 0.13
S2 complexes
G complex 27.60 3.30 25.11 0.81
G uncomplexed 27.39 4.44 22.95 0.00
G 0.21 1.14 2.16 0.81
All energies are given in kcal/mol. A, G, S stand for DNP-Ala, DNP-Gly,
DNP-Ser, respectively. S1 and S2 refer to complexation at the two different
subsites.
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precise values are obtained (standard deviations of 0.4
kcal/mol for the overall averages). The perturbation of
DNP-Ser to DNP-Gly is somewhat more demanding and
requires the deletion of a larger fragment. This is reflected
by the necessity to use electrostatic decoupling to reduce
numerical problems and avoid instabilities in the simula-
tions. However, the error associated with this transforma-
tion may still be significantly larger than for the other two
mutations. The hysteresis shows generally larger values,
and it is probably only by chance that it vanishes almost
completely in the longest simulation. The average result,
however, fits the values of the other two mutations very well
and perfectly closes the cycle.
Relative free energies of binding require as a second step
the calculation of mutational free energies of the ligands
complexed to their receptor. The results for the perturba-
tions of DNP-Ala, DNP-Gly, and DNP-Ser into each other
when bound to Lb4 are shown in the lower half of Table 5.
The simulations for both types of complexation (at S1 and
S2) are presented. Because these simulations are computa-
tionally much more demanding, series of simulations with
varying times of equilibration and data collection have been
carried out for only one example (DNP-Ala to DNP-Gly).
In the case of DNP-Ala to DNP-Gly at S1, the standard
deviation (0.46 kcal/mol) for the average result (28.70
kcal/mol) of this set is the same size as for the uncomplexed
DNP-Ala to DNP-Gly mutations, and essentially the same
result is obtained for the 168-ps simulation as for the 420-ps
simulation. Because of the similarity of the investigated
systems, it might be expected that the average values ob-
tained from forward and backward simulations of 168 ps
could already be good estimates for results of longer sim-
ulations. Furthermore, the cycle closure error is again very
low, with 0.13 kcal/mol for the S1 simulations.
The performance of the S2 simulations does not appear to
be as good, with a higher cycle closure error of 0.81 kcal/
mol and a very large hysteresis for the DNP-Ala to DNP-
Gly mutation over 168 ps. The series with increasing sim-
ulation lengths does not provide as consistent results as the
S1 simulation series, although the average 168-ps and
420-ps results are again comparable in size. Possible struc-
tural explanations for this behavior of the S2 simulations are
given below. In comparison to S1 binding, the obtained free
energies differ considerably for all three mutations of S2
complexes.
The combination of the results of the uncomplexed and
the complexed simulations provides the relative free ener-
gies of binding, which can be compared with the experi-
mental data, as shown in Table 6. For the mutations in
solution the overall averages are used; for the complex
mutations the results of the 168-ps simulations are used.
For the S1 complexes, the calculated G values com-
pare well with experiment. The slight preference of DNP-
Ser over DNP-Ala by 0.2 kcal/mol is almost exactly repro-
duced. The preference for DNP-Gly over DNP-Ala and
DNP-Ser is somewhat overestimated (G for DNP-Ala to
DNP-Gly: calculated 1.50 kcal/mol, experimental 0.7
kcal/mol; for DNP-Ser to DNP-Gly: calculated 1.35 kcal/
mol, experimental 0.5 kcal/mol). The obtained ranking is
correct, with DNP-Gly predicted to bind better than DNP-
Ser and the latter better than DNP-Ala.
For binding to S2, the simulation results do not compare
well with experiment, except for the DNP-Ala to DNP-Gly
value (0.21 kcal/mol calculated versus 0.7 kcal/mol
experimental), which, however, is associated with the larg-
est uncertainty of all G values due to the large hysteresis
of the complex simulation (see Table 5). DNP-Ala is incor-
rectly predicted to bind better than DNP-Ser, and the favor-
ing of DNP-Gly over DNP-Ser is largely overestimated.
Furthermore, the values are inconsistent among each other
because of the cycle closure error propagated from the S2
complex simulations.
Structural analysis
A requirement for sensible results of free energy calcula-
tions by MD simulations is that the structures are stable
along the trajectory. To analyze this, rms deviations of the
C-	 atoms have been calculated and are shown in Table 7.
The values are averages over the entire trajectory, with the
exception of the MD equilibration, of which only the last 20
ps has been used to calculate the average. For the MD
equilibration, the reference structure is the starting structure
(the original Lb4 model, with the ligand in the docked
position). For the free energy simulations, the measure-
ments refer to the average structure obtained from the last
20 ps of MD equilibration. The starting model obtained by
homology modeling and docking would be a somewhat
ambiguous reference structure. In fact, MD equilibration is
expected to lead to some changes in the initial structure due
to the inclusion of solvent and the full flexibility of the
protein, which may result in optimized interactions with the
ligand.
The average rms deviations from the starting structure are
in the range of 1.5–2 Å for the four MD equilibrations,
which are acceptable values, given the special nature of the
starting structure. For the free energy perturbations, the rms
deviations are generally around or below 1.7 Å, except for
the backward simulations of the DNP-Ser to DNP-Gly
mutations. The best performance is again observed for the
DNP-Ala to DNP-Gly mutations. The increasing trend in
the rms value observed for all simulations when continuing
in the backward direction is still within acceptable bound-
aries, although it suggests some drift.
Besides the stability of the overall antibody structure,
special attention is devoted to the binding site and the
behavior of the ligand within it. This is true first of all for
the phase of MD equilibration, which may be considered a
kind of optimization of the initial model. Visual inspection
of the final structures of the MD equilibration in comparison
with the starting structures shows what changes have oc-
curred. In the S1 complexes of Lb4 with DNP-Ala and
DNP-Ser, the ligand is shifted toward Tyr H32 (and away
from Tyr L49 and Lys L50) in such a way that the interac-
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tion surface with this Tyr side chain is increased and the
coplanar stacking of the aromatic rings is improved.
Thereby the phenyl ring of the ligand is somewhat rotated
around its central (pseudo C6) axis. As a consequence, both
nitro groups are more deeply buried within the pocket. In
contrast, the amino acid side chain is more solvent exposed,
and the hydrogen bonds of the carboxylate with Tyr L49
and Lys L50 are replaced by hydrogen bonds with water
molecules. The position of the ligand appears to be im-
proved within the binding site, with a tighter fit reflected by
an increased number of atomic contacts. Quite importantly,
DNP-Ala and DNP-Ser assume almost identical binding
orientations.
This is not the case for the S2 complexes with DNP-Ala
and DNP-Ser, in which the initial slight differences between
the docked structures become more pronounced during MD
equilibration. For DNP-Ala the orientation of the nitro
groups remains almost unchanged, with the ortho nitro
pointing toward CDR H3 and the para nitro oriented toward
CDR L3. The aromatic ring is somewhat tilted away from
His L27D and is no longer pointing vertically into the
pocket. Although the amino acid side chain is more solvent
exposed, the carboxylate is now hydrogen-bonded with Asn
L28. For DNP-Ser, in contrast, the carboxylate has become
completely solvent exposed, whereas the hydroxyl is within
hydrogen-bonding distance to Leu H97. The aromatic ring
is even more tilted than in the case of DNP-Ala and now is
in closer contact with CDR H3 residues. The nitro groups,
finally, are not as deeply buried as those of DNP-Ala and do
not show any good possibility for hydrogen bonds.
The described local changes are also reflected in the rmsd
and distance measurements listed in Tables 7 and 8. For
these analyses the most important contact residues of both
subsites have been selected, based on the final simulation
structures (not the docking structures). Compared to Table
4, this new list of contact residues also reflects some of the
changes observed during equilibration and provides a better
reference for the analyses of the free energy simulations.
For S1 the binding site is defined by Tyr H27, Thr H28, Tyr
H32, Arg H94–Phe H99, and Tyr H102, whereas S2 is
formed by Tyr H52, Trp H95, Leu H97, Ile H98, His L27D,
Tyr L32, Gly L91, Ser L92, and Val L94–Leu L96. The
heavy atoms of these residues are used for rms fitting, as
well as for evaluation of the subsite centers. For the ligands
the atoms of the aromatic part (including the nitro groups
and the amino nitrogen, a total of 16 atoms) are used for the
measurements, because these belong to the conserved part
of the molecule and are not subject to torsional flexibility,
facilitating positional measurements and comparisons
among the three molecules.
During MD equilibration of the S1 complexes, the side
chains of the contact residues show somewhat larger adjust-
ments than the overall C-	 structure (2.70 Å and 1.85 Å).
TABLE 8 Trajectory averages of distances (in Å) measured
in the complex simulations, in comparison with the
starting values
A complex S complex A 3 G S 3 A S 3 G
Distance from ligand center to subsite center
S1 starting structure 5.25 5.88
S1 MD equilibration 3.62 3.99
S1 4/4/168 forward 4.18 4.13 4.55
S1 4/4/168 reverse 3.99 5.54 5.25
S2 starting structure 3.30 2.29
S2 MD equilibration 2.91 3.12
S2 4/4/168 forward 4.16 2.95 2.82
S2 4/4/168 reverse 5.53 2.57 5.42
Distance from ligand center to Tyr H32
S1 starting structure 4.83 5.41
S1 MD equilibration 4.09 3.69
S1 4/4/168 forward 3.85 3.59 3.76
S1 4/4/168 reverse 3.70 3.84 3.81
A, G, S stand for DNP-Ala, DNP-Gly, DNP-Ser, respectively. S1 and S2
denote the two different subsites.
TABLE 7 Trajectory averages of rms deviations (in Å) observed in the complex simulations for the C- atoms, the binding site
residues, and the ligand
DNP-Ala S1 DNP-Ala S2 DNP-Ser S1 DNP-Ser S2
MD equilibration
C-	 1.88 1.78 1.48 2.09
b.s. 2.70 2.29 1.85 2.85
Ligand 3.33 1.71 3.34 3.33
A 3 G S1 A 3 G S2 S 3 A S1 S 3 A S2 S 3 G S1 S 3 G S2
4/4/168 forward runs
C-	 0.95 1.10 0.98 1.23 1.62 1.47
b.s. 1.10 1.04 1.16 1.51 1.26 1.71
Ligand 2.08 1.80 1.07 1.43 2.35 1.63
4/4/168 reverse runs
C-	 1.30 1.36 1.62 1.74 2.42 1.90
b.s. 1.41 1.43 2.51 2.24 1.68 2.46
Ligand 1.75 3.17 2.50 1.66 3.90 4.10
A, G, S stand for DNP-Ala, DNP-Gly, DNP-Ser, respectively. S1 and S2 denote the two different subsites. Further explanations regarding details of the
measurements are given in the text. b.s., binding site residues.
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The rms shift for both DNP-Ala and DNP-Ser in S1 is3.3
Å. The direction of this movement is immediately visible
from the distance measurements: the distance of the ligand
to the subsite center decreases from over 5 Å to below 4 Å
in both cases. This is accompanied by a closer contact with
the side chain of Tyr H32 (the distances in the table are
measured between the centers of the two aromatic rings).
This residue, in fact, turns out to be the most important
interaction partner. The “stacking” binding mode with Tyr
H32 is strictly conserved throughout all S1 free energy
simulations, as shown by average values between 3.6 and
3.9 Å. Variations in the orientation of the ligand as reflected
by slightly varying rms values and S1 center distances are
the consequences of rotations in the plane of the aromatic
ring and concerted fluctuations of the Tyr-DNP pair.
For the S2 complexes such a clear and conserved binding
mode is not observed. The ligands appear to be rather
loosely bound and show considerable flexibility during the
simulation. This is underlined by the comparatively large
fluctuations in the measured rms deviations, which assume
values of up to 1.05 Å (fluctuations are not shown in the
tables). The differences in orientation between the ligands
and their positional fluctuations during the simulations are
also reflected by the distances to the subsite center, which
vary between 2.6 and 5.5 Å.
Discussion of free energy calculations
The structural findings presented above lend further support
to the significance of the S1 results and provide possible
explanations of why the S2 free energy calculations are
inconsistent with experimental binding energies. Appar-
ently, S2 is not suited to accommodate the ligands as well as
S1, a fact that has already been indicated by the less favor-
able docking energies in S2. The larger differences in bind-
ing orientations and the higher fluctuations within the S2
binding site suggest that merely weaker interactions are
possible in S2 and that, in comparison, only binding in S1
may lead to the free energies observed experimentally.
Based on the simulation results, S1 thus appears to be the
optimal binding site of Lb4 for DNP ligands. Nevertheless,
the S2 pocket should not completely be ruled out as a
possible alternative site, given that because of larger fluc-
tuations and differences in binding orientations in this site,
the calculated free energies are expected to be associated
with larger errors (in contrast, other sources of numerical
errors, such as the removal or insertion of atoms, should
affect both the S1 and the S2 calculations in a similar way).
The S1 binding mode also allows us to rationalize the
experimental binding energies in their absolute and relative
sizes. The small differences in binding energy between
DNP-Ala, DNP-Gly, and DNP-Ser are consequences of the
fact that the major interaction partner is the common DNP
moiety, whereas the amino acid side chain is, to a large
extent, solvent exposed. Therefore, the differences in bind-
ing energy primarily arise from varying solvation prefer-
ences, which are only slightly modulated by the protein
environment. The low affinity of the binding interaction can
be understood from the lack of a deep burial of the whole
molecule within a binding pocket. In fact, the ligand is kept
in its bound state by not much more than the “stacking”
interaction with Tyr H32 and some weak hydrogen bonds to
the nitro groups.
To obtain the results presented here for the complex
systems, a total of 5.3 ns of simulation time was required (a
further 7.8-ns total simulation time was necessary for the
uncomplexed systems). Using periodic solvent boxes and
fully solvated and unconstrained systems, this is at the limits
of what is currently feasible. Nevertheless, this setup was
used because it represents a better and less artificial choice
for performing MD simulations than other, less expensive
variants. Furthermore, it has two advantages in the context
of free energy calculations. First, it does not lead to any
artificial contributions that may arise from extended wall
region boundary conditions (van Gunsteren and Mark,
1992) or probably even from constraints on the complex
itself (Lee, 1992). Second, it makes it possible to invoke a
certain error cancellation effect due to the identical treat-
ment of both legs of the thermodynamic cycle, i.e., the
mutation of the free ligand in solution and its transformation
in the antibody complex (van Gunsteren, 1993).
Instead of performing only one very long simulation, we
repartitioned the total time to obtain indications about the
quality of the calculations. Series of simulations of varying
length have been carried out: the results were stable within
reasonable boundaries. On the other hand, the study was
designed in such a way that a closed cycle could be formu-
lated among the investigated systems, allowing for an extra
check of the reliability of the results: very low cycle closure
errors were obtained. Taken together, these results suggest
the simulations to be of sufficient quality to permit useful
insights into the binding properties of antibody Lb4.
CONCLUSIONS
The binding of DNP-Ala, DNP-Gly, and DNP-Ser to anti-
body IgE Lb4 has been analyzed. Microcalorimetric mea-
surements found the free energy of binding to be in the
range of7.3 to6.6 kcal/mol, with DNP-Gly binding best
and DNP-Ala showing the weakest interaction. These ex-
perimental findings were analyzed and rationalized in struc-
tural terms by a “complete” modeling study. The starting
point was an antibody structure obtained by homology
modeling (Droupadi et al., 1994). Extensive docking
searches were carried out to localize possible binding sites
for the three ligands, whereby two subsites (S1 and S2)
within the CDRs were identified as the most probable
candidates for interaction. Free energy calculations were
performed for complexation in both subsites. Given the
special nature of the ligands, it was possible to form a closed
cycle of transformations among them and thus to obtain an
additional criterion for the reliability of the calculated free
energy values. The cycle closure errors were, in general,
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very low, suggesting sufficiently high consistency of the
results.
The experimental free energy differences could be repro-
duced only for binding to S1. Structural analysis of the
simulation trajectories showed the S1 complexes to be char-
acterized by a uniform binding mode, whereas ligand bind-
ing in S2 exhibited considerable variability. Furthermore,
the binding mode in S1 is consistent with the low affinity
and the small differences in binding energy between the
three ligands: the packing is tight on one side of the mole-
cule only, and the conserved DNP part is the major inter-
action partner. In summary, S1 is expected to be the “real”
binding site of these DNP-ligands.
One merit of the presented computational studies is that
they were carried out in an ab initio fashion, without any
detailed experimental structural information as input. The
combination of different standard computational techniques
proved to be a valid approach for obtaining structural in-
sights, because experimental free energy differences could
be reproduced with the resulting models of the complexes.
Most encouraging for further investigations of protein-li-
gand interactions is the fact that even relatively low affinity
complexation and differences in fine specificity can be
analyzed with reasonable accuracy. Nevertheless, it is clear
that because of various methodological limitations, the pre-
dictive nature of the results remains associated with some
uncertainty. The predictions should therefore be tested in
future by experimental structural determinations using x-ray
crystallography or NMR techniques.
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